| 1 |
Guideline Moving toward assured access to treatment in microbicide trials. Global Campaign for Microbicides. free! 2006
Forbes A. · Global Campaign for Microbicides, Washington, DC, USA. · PLoS Med. · Pubmed #16805648 links to free full text
This publication has no abstract.
|
| 2 |
Guideline Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. 2005
Mofenson LM, Oleske J, Serchuck L, Van Dyke R, Wilfert C. · National Institutes of Health, Bethesda, Maryland, USA. <> · Clin Infect Dis. · Pubmed #15655768 No free full text.
Abstract: In 2001, CDC, the National Institutes of Health, and the Infectious Diseases Society of America convened a working group to develop guidelines for therapy of human immunodeficiency virus (HIV)-associated opportunistic infections to serve as a companion to the Guidelines for Prevention of Opportunistic Infections Among HIV-Infected Persons. In recognition of unique considerations related to HIV infection among infants, children, and adolescents, a separate pediatric working group was established.Because HIV-infected women coinfected with opportunistic pathogens might be more likely to transmit these infections to their infants than women without HIV infection, guidelines for treating opportunistic pathogens among children should consider treatment of congenitally acquired infections among both HIV-exposed but uninfected children and those with HIV infection. In addition, the natural history of opportunistic infections among HIV-infected children might differ from that among adults. Compared with opportunistic infections among HIV-infected adults, which are often caused by reactivation of pathogens acquired before HIV infection when host immunity was intact, opportunistic infections among children often reflect primary acquisition of the pathogen and, among children with perinatal HIV infection, infection acquired after HIV infection has been established and begun to compromise an already immature immune system. Laboratory diagnosis of opportunistic infections can be more difficult with children. Finally, treatment recommendations should consider differences between adults and children in terms of drug pharmacokinetics, dosing, formulations, administration, and toxicities. This report focuses on treatment of opportunistic infections that are common in HIV-exposed and infected infants, children, and adolescents in the United States.
|
| 3 |
Guideline BHIVA Guidelines: coinfection with HIV and chronic hepatitis B virus. 2003
Brook MG, Gilson R, Wilkins EL, Anonymous00075. · Central Middlesex Hospital, London, UK. · HIV Med. · Pubmed #14511247 No free full text.
This publication has no abstract.
|
| 4 |
Guideline British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. 2003
Pozniak A, Gazzard B, Anderson J, Babiker A, Churchill D, Collins S, Fisher M, Johnson M, Khoo S, Leen C, Loveday C, Moyle G, Nelson M, Peter B, Phillips A, Pillay D, Wilkins E, Williams I, Youle M, Anonymous00074. · Chelsea and Westminster Hospital, London, UK. · HIV Med. · Pubmed #14511246 No free full text.
This publication has no abstract.
|
| 5 |
Guideline Canadian consensus guidelines for the management of pregnancy, labour and delivery and for postpartum care in HIV-positive pregnant women and their offspring (summary of 2002 guidelines). free! 2003
Burdge DR, Money DM, Forbes JC, Walmsley SL, Smaill FM, Boucher M, Samson LM, Steben M, Anonymous00199. · Oak Tree Clinic, Children's and Women's Health Centre of British Columbia and University of British Columbia, Vancouver, BC. · CMAJ. · Pubmed #12821620 links to free full text
This publication has no abstract.
|
| 6 |
Guideline To tell or not to tell: breaching confidentiality with clients with HIV and AIDS. 1999
Hook MK, Cleveland JL. · No affiliation provided · Ethics Behav. · Pubmed #11657656 No free full text.
This publication has no abstract.
|
| 7 |
Guideline Recommendations on feeding infants of HIV positive mothers. WHO, UNICEF, UNAIDS guidelines. 2000
Savage DF, Lhotska L, Anonymous00043, Anonymous00044, Anonymous00045. · Department of Child and Adolescent Health and Development, World Health Organisation, Geneva. · Adv Exp Med Biol. · Pubmed #11065075 No free full text.
This publication has no abstract.
|
| 8 |
Guideline Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. free! 2000
Anonymous57304. · No affiliation provided · Thorax. · Pubmed #10679540 links to free full text
This publication has no abstract.
|
| 9 |
Guideline Criteria for assessing cutaneous anergy in women with or at risk for HIV infection. HIV Epidemiologic Research Study Group. 1999
Klein RS, Flanigan T, Schuman P, Smith D, Vlahov D. · Division of Infectious Diseases, Department of Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY 10467, USA. Disease, Department of Medicine, · J Allergy Clin Immunol. · Pubmed #9893191 No free full text.
Abstract: BACKGROUND: Controversy exists about both the clinical utility of anergy testing and the optimal criteria for defining anergy. OBJECTIVE: We sought to assess various definitions of cutaneous anergy for ability to distinguish HIV status, level of immunodeficiency, and ability to mount a tuberculin reaction among women with or at risk for HIV infection. METHODS: HIV-seropositive (n = 721) and HIV-seronegative (n = 358) at-risk women at academic medical centers in Baltimore, Detroit, New York, and Providence had cutaneous testing with mumps, Candida, tetanus toxoid, and tuberculin antigens. Associations with HIV status and CD4+ lymphocyte levels were analyzed. RESULTS: Candida, mumps, and tetanus antigens alone or in combination elicited reactions significantly less often in HIV-seropositive than in HIV-seronegative women and less often in seropositive women with lower CD4+ counts, regardless of induration cutpoint chosen to define a positive reaction. The best antigen combinations for distinguishing groups included tetanus and mumps. Some women nonreactive to the 3 antigens ("anergic") had positive tuberculin reactions among both seropositive subjects (range, 1.1% to 2.9% depending on induration cutpoint for defining anergy) and seronegative subjects (range, 8.9% to 14%). CONCLUSION: Absence of reactions to Candida, mumps, and tetanus antigens alone or in combination and at any induration cutpoint is associated with HIV status and with CD4+ level. Combinations, including tetanus and mumps antigens with an induration cutpoint of less than 2 mm, may be the best for defining anergy.
|
| 10 |
Editorial The continuing evolution of research on sexually transmitted infections among men who have sex with men. 2008
Stall R, Hart G. · No affiliation provided · Sex Transm Infect. · Pubmed #19028935 No free full text.
This publication has no abstract.
|
| 11 |
Editorial Monitoring HIV epidemiology using assays for recent infection: where are we? free! 2008
Barin F, Nardone A. · No affiliation provided · Euro Surveill. · Pubmed #18775294 links to free full text
This publication has no abstract.
|
| 12 |
Editorial HIV/AIDS, pregnancy and reproductive autonomy: rights and duties. 2008
Ngwena CG, Cook RJ. · No affiliation provided · Dev World Bioeth. · Pubmed #18315720 No free full text.
This publication has no abstract.
|
| 13 |
Editorial Trichomonas vaginalis infection: can we afford to do nothing? 2008
McClelland RS. · No affiliation provided · J Infect Dis. · Pubmed #18275270 No free full text.
This publication has no abstract.
|
| 14 |
Editorial Can Zuma lead South Africa to a healthy future? 2008
Anonymous120481. · No affiliation provided · Lancet. · Pubmed #18191666 No free full text.
This publication has no abstract.
|
| 15 |
Editorial Preserved cognitive functioning over time in asymptomatic HIV-infected people in the MACS cohort. 2007
Cohen RA, Navia BA. · No affiliation provided · Neurology. · Pubmed #18071140 No free full text.
This publication has no abstract.
|
| 16 |
Editorial HIV vaccine trials: reconsidering the therapeutic misconception and the question of what constitutes trial related injuries. 2007
Schüklenk U, Ashcroft R. · No affiliation provided · Dev World Bioeth. · Pubmed #18021115 No free full text.
This publication has no abstract.
|
| 17 |
Editorial A cure for AIDS? 2007
Laurence J. · No affiliation provided · AIDS Read. · Pubmed #17672011 No free full text.
This publication has no abstract.
|
| 18 |
Editorial Old habits die hard. 2007
Anonymous116055. · No affiliation provided · Lancet Infect Dis. · Pubmed #17521586 No free full text.
This publication has no abstract.
|
| 19 |
Editorial HIV coreceptor use in heavily treatment-experienced patients: does it take two to tangle? 2007
Melby T. · No affiliation provided · Clin Infect Dis. · Pubmed #17243066 No free full text.
This publication has no abstract.
|
| 20 |
Editorial Cirrhosis is associated with low CD4+ T cell counts: implications for HIV-infected patients with liver disease. 2007
Gandhi RT. · No affiliation provided · Clin Infect Dis. · Pubmed #17205455 No free full text.
This publication has no abstract.
|
| 21 |
Editorial HIV/AIDS and employment: the continuing challenge. 2006
Braveman B, Kielhofner G. · No affiliation provided · Work. · Pubmed #17066575 No free full text.
This publication has no abstract.
|
| 22 |
Editorial Treatment of acute HIV-1 infection: is it coming of age? 2006
Kinloch-de Loes S. · No affiliation provided · J Infect Dis. · Pubmed #16941336 No free full text.
This publication has no abstract.
|
| 23 |
Editorial Primary mania versus secondary mania of HIV/AIDS in Uganda. free! 2006
Robinson RG. · No affiliation provided · Am J Psychiatry. · Pubmed #16877637 links to free full text
This publication has no abstract.
|
| 24 |
Editorial Diagnosing, preventing and managing sexually transmitted diseases in persons living with HIV/AIDS. free! 2006
Levy I. · No affiliation provided · Isr Med Assoc J. · Pubmed #16805238 links to free full text
This publication has no abstract.
|
| 25 |
Editorial HIV/AIDS in Pakistan: has the explosion begun? 2006
Vermund SH, White H, Shah SA, Altaf A, Kristensen S, Khanani R, Mujeeb SA. · No affiliation provided · J Pak Med Assoc. · Pubmed #16689472 No free full text.
This publication has no abstract.
|
Next |
|
|